Helus Pharma Phase 3 MDD trial surpasses 86% enrollment

June 24, 2026 6:00 AM

Helus Pharma (Nasdaq: HELP) (Cboe CA: HELP) announced that enrollment in its APPROACH Phase 3 clinical trial of HLP003 for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found